Marcaine is one of 96 small molecule programs targeting Hernia. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
357 competitors in Migraine
Marcaine
Aimovig
Emgality
Vyepti
Bayer Aspirin
Savella
Cervidil
Cymbalta
Botox
Adempas
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details